Obese Patients With or Without Comorbidities (RIO-North America)

Efficacy and Safety of Rimonabant With or Without Hypocaloric Diet in Obese Patients

NCT00481923 ·Status: COMPLETED ·Phase: PHASE3

Comprehensive Rimonabant Evaluation Study of Cardiovascular ENDpoints and Outcomes

NCT00263042 ·Status: TERMINATED ·Phase: PHASE3

Rimonabant in Abdominally Obese Patients With Impaired Fasting Blood Glucose

NCT00405808 ·Status: TERMINATED ·Phase: PHASE3

Long-Term Effect of 10 mg Versus 20 mg Rimonabant in Overweight or Obese Patients

NCT00678483 ·Status: TERMINATED ·Phase: PHASE3

Efficacy and Safety of Rimonabant on Weight Loss and Frequency of Binge Episodes in Obese Patients

NCT00481975 ·Status: COMPLETED ·Phase: PHASE3

VIsceral Fat Reduction Assessed by CT-scan On RImonabAnt

NCT00299325 ·Status: COMPLETED ·Phase: PHASE3

A Study Evaluating the Effect of Daily Oral RO7795081 in Participants With Obesity or Overweight With at Least One Weight-Related Comorbidity

NCT07081958 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2

High Density Lipoprotein Turnover

NCT00408148 ·Status: TERMINATED ·Phase: PHASE3

Research Study Investigating How Well Semaglutide Works in People Suffering From Overweight or Obesity

NCT03548987 ·Status: COMPLETED ·Phase: PHASE3

Evaluation of the Rimonabant Impact on the Regression of Asymptomatic Damage Caused by Cardiovascular Risk Factors

NCT00458081 ·Status: TERMINATED ·Phase: PHASE3

Investigation of Safety and Efficacy of Once-daily Semaglutide in Obese Subjects Without Diabetes Mellitus

NCT02453711 ·Status: COMPLETED ·Phase: PHASE2

Latino Semaglutide Study

NCT05087342 ·Status: COMPLETED ·Phase: PHASE3

Safety and Efficacy Study of S-309309 in Obese Adults

NCT05925114 ·Status: COMPLETED ·Phase: PHASE2

Phase 2 Study to Evaluate Safety and Efficacy of RM-493 in Obese Participants

NCT01749137 ·Status: COMPLETED ·Phase: PHASE2

The Effect of Rimonabant on Energy Expenditure, Fat Metabolism and Body Composition

NCT00584389 ·Status: TERMINATED ·Phase: PHASE4

A Research Study to See How Well Semaglutide Helps People Who Have a Body Weight Above the Healthy Weight Range

NCT06041217 ·Status: COMPLETED ·Phase: PHASE3

A Multicenter Study to Evaluate the Efficacy and Safety of of Four Doses of SR147778 in Obese Patients

NCT00239174 ·Status: COMPLETED ·Phase: PHASE2

The Efficacy and Safety of Liraglutide on Body Weight Loss in Obese and Overweight Patients

NCT04605861 ·Status: COMPLETED ·Phase: PHASE3

Efficacy and Safety of ATL-962 in Obese Diabetics

NCT00156897 ·Status: COMPLETED ·Phase: PHASE2

A Study of LY3502970 in Participants With Obesity or Overweight With Weight-related Comorbidities

NCT05051579 ·Status: COMPLETED ·Phase: PHASE2

A Research Study of How NNC0174-0833 Taken With Semaglutide Works in People Who Are Overweight or Obese

NCT03600480 ·Status: COMPLETED ·Phase: PHASE1

Effect and Safety of Liraglutide 3.0 mg in Subjects With Overweight or Obesity and Type 2 Diabetes Mellitus Treated With Basal Insulin

NCT02963922 ·Status: COMPLETED ·Phase: PHASE3

A Study to Test Different Doses of BI 456906 in Patients With Obesity

NCT03591718 ·Status: COMPLETED ·Phase: PHASE1

The Effect of SHR20004（Noiiglutide ） on Body Weight in Obese Subjects Without Diabetes

NCT04799327 ·Status: UNKNOWN ·Phase: PHASE2

A Study to Evaluate the Safety and Efficacy of JNJ-64565111 in Non-diabetic Severely Obese Participants

NCT03486392 ·Status: COMPLETED ·Phase: PHASE2